Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
for Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
11 locations incl. Centennial
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT05327114·Phase 2, Phase 3·Recruiting·Listed Apr 2022